22.77
0.16 (0.71%)
0.16 (0.71%)
Upgrade to Real-Time
Afterhours (Closed)
Low
17.96
High
63.69
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tarsus Pharmaceuticals Inc | TARS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.16 | 0.71% | 22.77 | 18:20:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 22.77 | 21.618 | 22.90 | 22.77 | 22.61 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 17.92 | 42.38 | 24.46 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 285 | 26,053 | $ 22.70 | $ 591,285 | - | 17.96 - 63.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:31:45 | 40 | $ 22.77 | USD |
Period:
Draw Mode:
Tarsus Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 468.47M | 20.57M | 8.84M | $ - | $ - | -4.52 | -6.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 119.35k | 7.50% |
Tarsus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 23.38 | 25.24 | 21.46 | 22.70 | 34,378 | -0.61 | -2.61% |
| 1 Month | 24.31 | 28.05 | 21.46 | 24.15 | 28,458 | -1.54 | -6.33% |
| 3 Months | 30.01 | 30.8499 | 21.46 | 26.04 | 36,874 | -7.24 | -24.13% |
| 6 Months | 33.32 | 39.08 | 21.46 | 29.33 | 51,718 | -10.55 | -31.66% |
| 1 Year | 18.30 | 63.69 | 17.96 | 33.37 | 63,767 | 4.47 | 24.43% |
| 3 Years | 18.30 | 63.69 | 17.96 | 33.37 | 63,767 | 4.47 | 24.43% |
| 5 Years | 18.30 | 63.69 | 17.96 | 33.37 | 63,767 | 4.47 | 24.43% |
Tarsus Pharmaceuticals Description
| Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. |
